Clinical Trial Update: Multimodal Biomarkers for Diagnosis and Prognosis in VCI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating multimodal biomarkers for diagnosis and prognosis in vascular cognitive impairment and Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Vascular Cognitive Impairment

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Vascular Cognitive Impairment, Alzheimer Disease | Phase 3 | Status: UNKNOWN